- Home
- DNTH vs WGO Comparison
DNTH vs WGO Comparison
Compare DNTH & WGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- WGO
- Stock Information
- Founded
- DNTH 2015
- WGO 1958
- Country
- DNTH United States
- WGO United States
- Employees
- DNTH N/A
- WGO N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- WGO Homebuilding
- Sector
- DNTH Health Care
- WGO Industrials
- Exchange
- DNTH Nasdaq
- WGO Nasdaq
- Market Cap
- DNTH 780.2M
- WGO 893.6M
- IPO Year
- DNTH N/A
- WGO N/A
- Fundamental
- Price
- DNTH $26.50
- WGO $36.78
- Analyst Decision
- DNTH Strong Buy
- WGO Buy
- Analyst Count
- DNTH 8
- WGO 11
- Target Price
- DNTH $54.00
- WGO $39.60
- AVG Volume (30 Days)
- DNTH 374.5K
- WGO 483.1K
- Earning Date
- DNTH 11-06-2025
- WGO 10-22-2025
- Dividend Yield
- DNTH N/A
- WGO 3.70%
- EPS Growth
- DNTH N/A
- WGO N/A
- EPS
- DNTH N/A
- WGO N/A
- Revenue
- DNTH $4,854,000.00
- WGO $2,741,800,000.00
- Revenue This Year
- DNTH N/A
- WGO N/A
- Revenue Next Year
- DNTH N/A
- WGO $5.92
- P/E Ratio
- DNTH N/A
- WGO N/A
- Revenue Growth
- DNTH 17.87
- WGO N/A
- 52 Week Low
- DNTH $13.37
- WGO $28.00
- 52 Week High
- DNTH $32.27
- WGO $65.65
- Technical
- Relative Strength Index (RSI)
- DNTH 70.68
- WGO 63.67
- Support Level
- DNTH $22.81
- WGO $34.78
- Resistance Level
- DNTH $24.81
- WGO $36.79
- Average True Range (ATR)
- DNTH 1.57
- WGO 1.16
- MACD
- DNTH 0.22
- WGO 0.06
- Stochastic Oscillator
- DNTH 91.57
- WGO 80.26
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About WGO Winnebago Industries Inc.
Winnebago Industries manufactures Class A, B, and C motor homes along with towables, customized specialty vehicles, boats, and parts. Headquartered in Eden Prairie, Minnesota, Winnebago has been producing recreational vehicles since 1958. Revenue was nearly $3 billion in fiscal 2024. Winnebago expanded into towables in 2011 with the acquisition of SunnyBrook and acquired Grand Design in November 2016. Towables made up 83% of the firm's RV unit volume, up from 31% in fiscal 2016. The company's total RV unit volume was 38,796 in fiscal 2024. Winnebago expanded into boating in 2018 with the purchase of Chris-Craft, bought premium motor home maker Newmar in November 2019, and bought Barletta pontoon boats in August 2021. It also is developing electric and autonomous technology.